Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy

Por Doherty, Mark K, Morris, Patrick G
Publicado no Int J Womens Health (2015)

Monitoring and Management of Immune‐Related Adverse Events Associated With Programmed Cell Death Protein‐1 Axis Inhibitors in Lung Cancer

Por O'Kane, Grainne M., Labbé, Catherine, Doherty, Mark K., Young, Kelvin, Albaba, Hamzeh, Leighl, Natasha B.
Publicado no Oncologist (2016)